GLAUKOS Corp (GKOS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
GKOS currently has 57.2M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 19.17% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 04, 2025 |
10-Q filing | 57.2M shares outstanding |
57M | 0 |
| May 01, 2025 |
10-Q filing | 56.6M shares outstanding |
57M | 0 |
| Feb 25, 2025 |
10-K filing | 52.8M shares outstanding |
53M | 0 |
| Nov 05, 2024 |
10-Q filing | 55.0M shares outstanding |
55M | 0 |
| Oct 11, 2024 |
8-K filing: Glaukos Corporation issued a notice of redemption for all $57.5 million aggregate principal amount outstanding of its 2.75% Convertible Senior Notes due 2027. The Notes called for redemption may be converted by holders into shares of common stock of the Company at any time prior to 5:00 p.m. (New York City time) on December 13, 2024. The conversion rate for the Notes is 17.8269 shares of Common Stock per $1,000 principal amount, plus additional shares of 0.3501 per $1,000 principal amount in accordance with the terms and conditions of the Indenture, resulting in a total of 18.1770 shares of Common Stock per $1,000 principal amount surrendered for conversion. |
51M | 0 |
| Aug 02, 2024 |
10-Q filing | 50.7M shares outstanding |
51M | 0 |
| Jun 28, 2024 |
8-K filing: The Company closed exchange transactions with certain holders of its 2.75% Convertible Senior Notes due 2027, exchanging $230,000,000 in aggregate principal amount of the notes for 4,253,423 shares of the Company's common stock and cash. |
50M | 0 |
| May 03, 2024 |
10-Q filing | 49.6M shares outstanding |
50M | 0 |
| Feb 23, 2024 |
10-K filing | 48.4M shares outstanding |
48M | 0 |
| Nov 01, 2023 |
10-Q filing | 48.7M shares outstanding |
49M | 0 |
| Aug 02, 2023 |
10-Q filing | 48.3M shares outstanding |
48M | 0 |
| May 04, 2023 |
10-Q filing | 47.9M shares outstanding |
48M | 0 |
| Feb 24, 2023 |
10-K filing | 47.4M shares outstanding |
47M | 0 |
| Nov 04, 2022 |
10-Q filing | 47.6M shares outstanding |
48M | 0 |
| Aug 05, 2022 |
10-Q filing | 47.4M shares outstanding |
47M | 0 |
| May 05, 2022 |
10-Q filing | 47.1M shares outstanding |
47M | 0 |
| Feb 28, 2022 |
10-K filing | 46.4M shares outstanding |
46M | 0 |
| Nov 08, 2021 |
10-Q filing | 46.7M shares outstanding |
47M | 0 |
| Aug 05, 2021 |
10-Q filing | 46.6M shares outstanding |
47M | 0 |
| May 06, 2021 |
10-Q filing | 46.3M shares outstanding |
46M | 0 |
| Mar 01, 2021 |
10-K filing | 44.5M shares outstanding |
44M | 0 |
| Nov 05, 2020 |
10-Q filing | 45.0M shares outstanding |
45M | 0 |
| Aug 07, 2020 |
10-Q filing | 44.7M shares outstanding |
45M | 0 |
| Jun 12, 2020 |
8-K filing: Glaukos Corporation issued $250 million in Convertible Senior Notes due 2027 in a private offering, which are initially convertible into a maximum of 5,793,725 shares of common stock, or up to 6,662,784 shares if the Initial Purchasers exercise their option to purchase Additional Notes in full. |
44M | 0 |
| May 07, 2020 |
10-Q filing | 44.2M shares outstanding |
44M | 0 |
| Mar 02, 2020 |
10-K filing | 41.1M shares outstanding |
41M | 0 |